Continuous intravenous insulin infusion is initiated for certain liver transplant recipients in critical care settings, specifically those with severe hyperglycemia (blood glucose ≥ 250 mg/dL) after excluding hyperglycemic emergencies such as diabetic ketoacidosis or hyperosmolar hyperglycemic shock. Here, INS is linked to diabetic ketoacidosis.